Airwheel to Showcase Ai Wheel 20inch Carry-On Hand Scooter Robot Cabin Luxury Suitcase at the 140th Canton Fair 
GP Energy Tech, a subsidiary of Gold Peak, showcases Nickel-Zinc battery technology at Hong Kong Electronics Fair 
Kincora Announces Shares for Debt Settlement 
Digi Power X Announces $200 Million Debt Financing Commitment to Support Completion of Alabama AI Data Center and Provides Expansion Update 
Doubleview Gold Appoints George B. Darling, P.Eng., as Advisor to the Board Protolabs Reports Financial Results for the First Quarter of 2022
Revenue of $124.2 million in the First Quarter of 2022; GAAP Earnings Per Share of…
Orion enters into exclusive agreement with Jemincare for novel non-opioid drug candidate for the treatment of pain
ORION CORPORATION PRESS RELEASE 6 MAY 2022 at 9.00 EEST Orion enters into exclusive agreement with…
Duet Protocol Listed on DeFi Lama
Singapore, Singapore–(Newsfile Corp. – May 6, 2022) – A parallel universe that turns Flat Assets…
PepGen Announces Pricing of Initial Public Offering
BOSTON, May 05, 2022 (GLOBE NEWSWIRE) — PepGen, Inc., a clinical-stage biotechnology company advancing the…
Sudarshan Venu Elevated as Managing Director of TVS Motor Company
Singapore, May 6, 2022 – (ACN Newswire) – TVS Motor Company, a reputed manufacturer of…
LookPrior™ is the First Online Marketplace that Allows Videos of Products and Services
MULLICA HILL, N.J.–(BUSINESS WIRE)–#Buy–In an industry first, LookPrior™ marketplace allows users to upload videos, along…
Kolibri Global Energy Announces First Quarter 2022 Results
NEWBURY PARK, Calif.–(BUSINESS WIRE)–All amounts are in U.S. Dollars unless otherwise indicated: FIRST QUARTER HIGHLIGHTS…
Scilex, a Sorrento Company, Announces Pivotal Phase 3 SP-102 (SEMDEXA™) Data Presentation At The American Society Of Interventional Pain (ASIPP) 2022 Annual Meeting
SP-102 (SEMDEXATM) is the first non-opioid novel injectable corticosteroid gel formulation product in development for…
CORRECTION – Celyad Oncology Announces First Quarter 2022 Financial Results and Recent Business Highlights
MONT-SAINT-GUIBERT, Belgium, May 05, 2022 (GLOBE NEWSWIRE) — In a release issued under the same…
Cazoo Announces Filing of Annual Report on Form 20-F for Fiscal Year 2021
LONDON & NEW YORK–(BUSINESS WIRE)–Cazoo Group Ltd (NYSE: CZOO) (“Cazoo” or “the Company”), Europe’s leading…
PG&E to Launch New Pilots Studying Electric Vehicle Bidirectional Charging Technology at Homes, Businesses and with Microgrids
Three Pilot Programs Will Shape How Electric Vehicles Can Help Power the Grid and Benefit…
Wells Fargo Launches Military Spouse Hiring Program, Designed to Onboard 100 New Employees Per Year for the Next Five Years
The Military Spouse Homefront Heroes Hiring Program Provides Portable Career Opportunities in Mid- to High-Level…
Agile Therapeutics Announces Findings of First-Year Post-Marketing Pharmacovigilance in ACOG Poster Presentation
PRINCETON, N.J., May 05, 2022 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare…
Baudax Bio Announces Date of Reconvened Annual Meeting of Shareholders
Annual Meeting to be reconvened on May 18, 2022 MALVERN, Pa., May 05, 2022 (GLOBE…
Optinose Announces Reporting Date for First Quarter 2022 Financial Results
Conference Call and Webcast to be held May 12, 2022, at 8:00 a.m. Eastern Time…
Cellectis to Report First Quarter 2022 Financial Results
NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS –…
ProQR Announces First Quarter 2022 Operating and Financial Results
Post-hoc analyses from Illuminate trial of sepofarsen demonstrate an encouraging efficacy signal when comparing active…
Generation Bio Reports Business Highlights and First Quarter 2022 Financial Results
Company continues to optimize cell-targeted lipid nanoparticle (ctLNP) delivery system for nonviral genetic medicine applications…
ARCA biopharma Retains Ladenburg Thalmann to Support Strategic Options Review
WESTMINSTER, Colo., May 05, 2022 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO) today announced…
CytomX Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
– Patient enrollment completed in Arm A in the Phase 2 study of praluzatamab ravtansine…